Immunization

Preliminary findings suggest patients with multiple sclerosis who are taking cladribine can mount and maintain effective vaccine responses.

The FDA is allowing more flexible storage and transportation conditions for Pfizer-BioNTech’s COVID-19 vaccine.

The FDA has granted emergency use authorization status for the first single-dose vaccine for COVID-19 in the United States.

On Friday, a panel of advisors to the FDA voted to recommend Johnson & Johnson's COVID-19 vaccine, named Ad26.COV2.S, for emergency approval.

On Friday, an advisory panel will meet to evaluate the vaccine candidate and decide whether to recommend for emergency use authorization.

In our final interview segment, Lee Rosebush dives into improving vaccine distribution, addressing costs, and maintaining records while vaccinating for COVID-19.

In part 2 of our interview, Kaitlyn Rivard, PharmD, leads an insightful discussion on the practical side of administering COVID-19 vaccines.

In part 2 of our interview, Lee Rosebush offers pharmacist-centered guidance on regulation and compliance amid COVID-19 vaccinations.

Lee Rosebush of BakerHostetler law firm discussed how pharmacies can avoid regulatory and compliance issues amid their COVID-19 vaccination programs.

The MJH Life Sciences™ COVID-19 Coalition is hosting a live webinar event on the legal and ethical considerations of COVID-19 vaccination.

The US government has purchased 100 million more vaccine doses for COVID-19 to stay ahead of increasing demand.

Preventive efforts, renewed interest in vaccinations drive milder flu season.

The survey results also showed an increasing willingness among Americans to receive the vaccine.

The FDA advisory committee will meet in 3 weeks to discuss the Janssen investigational vaccine.

Pharmacists can employ several strategies to enhance these programs.

Starting February 11, federal vaccine supplies will be delivered directly to select pharmacies, according to the announcement.

The single-dose adenovirus-based vaccine candidate produced protective effects against moderate-to-severe COVID-19, as well as against multiple virus variants.

Experts presented safety data on the 2 currently authorized COVID-19 vaccines during a meeting of the CDC’s Advisory Committee on Immunization Practices.

The CDC’s Advisory Committee on Immunization Practices issued updates to its interim recommendations for mRNA COVID-19 vaccines.

The Biden administration announced efforts to boost COVID-19 vaccination supply and increase transparency.

A survey from APhA reported that the majority of pharmacists plan to or have received a COVID-19 vaccine.

Drug Topics interviews Naomi Lopez, director of healthcare policy at the Goldwater Institute, focusing on expanding scope of practice and COVID-19 vaccine candidates already being used in other countries.

In a letter to President Joe Biden, ASHP and more than 50 signers called for use of federal resources and expansion of the vaccinator workforce to confront the slow ramping up of COVID-19 vaccinations.

ISMP identified the most commonly reported errors and hazards associated with the new COVID-19 vaccines.

President-elect Joe Biden revealed his COVID-19 plan, which includes a disciplined focus on vaccination efforts.